| Literature DB >> 30441761 |
Giulia Sita1, Patrizia Hrelia2, Agnese Graziosi3, Fabiana Morroni4.
Abstract
Sulforaphane (Entities:
Keywords: apoptosis; chemoprevention; glioblastoma multiforme; sulforaphane
Mesh:
Substances:
Year: 2018 PMID: 30441761 PMCID: PMC6267435 DOI: 10.3390/nu10111755
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Chemical structures of (a) isothiocyanates (ITCs) and (b) sulforaphane (SFN).
Summary of studies focused on the anti-proliferative and pro-apoptotic properties of sulforaphane (SFN) in glioblastoma (GBM).
| Model | Dose | References |
|---|---|---|
| U251 | 10–40 μM | [ |
| T98G | 20–40 μM | [ |
| U87 | ||
| GBM 8401 | 12.5–50 μM | [ |
| U252 | 10–40 μM | [ |
| U87 | ||
| U87 | 5–30 μM | [ |
| M-HBT-32 | ||
| U373 | 30–70 μM | |
| U118 | ||
| SF767 | ||
| U87 spheroids | ||
| GBM43 spheroids | 10–50 μM | |
| M-HBT-161 spheroids | ||
| NSG 1 mice implanted with GBM10 cells | 100 mg/Kg/day per os | |
| T98G | 10–30 μM | [ |
| U87-R | ||
| U373-R |
1 NSG: NOD severe combined immunodeficiency gamma mice
Summary of studies focused on the anti-migration properties of SFN in GBM.
| Model | Dose | References |
|---|---|---|
| U87 | 10–30 μM | [ |
| U373 | ||
| U251 | 10–40 μM | [ |
| GBM 8401 | 2.5–10 μM | [ |
| T98G | 10–30 μM | [ |
| U87-R | ||
| U373-R |
Summary of main studies focused on the anti-chemo/radio resistance induced by SFN in GBM.
| Model | Dose | References |
|---|---|---|
| LN229 | 5–40 μM | [ |
| U251 | ||
| T98G | 10–30 μM | [ |
| U87-R | ||
| U373-R | ||
| Nude mice implanted with U373-R | 50 mg/Kg/day i.p. |
Figure 2Summary of the multiple signaling pathways of SFN in glioblastoma (GBM). SFN may induce apoptosis through endoplasmatic reticulum (ER) stress, or through the inhibition of survival signals and promotion of pro-apoptotic molecules. SFN is also able to reduce tumor invasiveness and to counteract chemoresistance.